Skip to main content
. 2021 Mar 19;5:PO.20.00321. doi: 10.1200/PO.20.00321

FIG A4.

FIG A4.

Association of molecular response with survival outcomes in treatment cohorts. Kaplan-Meier survival curves using a molecular response cutoff of 50% for (A) progression-free survival and (B) overall survival for patients treated with pembrolizumab monotherapy. Kaplan-Meier survival curves using a molecular response cutoff of 50% for (C) progression-free survival and (C) overall survival for patients treated with pembrolizumab plus chemotherapy. HR, hazard ratio.